{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T21:06:36Z","timestamp":1794258396292,"version":"4.9.0"},"reference-count":11,"publisher":"Japanese Society of Internal Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026]]},"DOI":"10.2169\/internalmedicine.7758-26","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:11:53Z","timestamp":1790633513000},"source":"Crossref","is-referenced-by-count":1,"title":["Successful Treatment with Rituximab in a Patient with Clinically Suspected Small-vessel Primary Central Nervous System Vasculitis Refractory to Cyclophosphamide Pulse Therapy"],"prefix":"10.2169","author":[{"given":"Takuya","family":"Okamoto","sequence":"first","affiliation":[{"name":"Department of Neurology, School of Medicine, Sapporo Medical University, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Yokokawa","sequence":"additional","affiliation":[{"name":"Department of Neurology, School of Medicine, Sapporo Medical University, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bungo","family":"Hirose","sequence":"additional","affiliation":[{"name":"Department of Neurology, School of Medicine, Sapporo Medical University, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naotoshi","family":"Iwahara","sequence":"additional","affiliation":[{"name":"Department of Neurology, School of Medicine, Sapporo Medical University, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syuuichirou","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Neurology, School of Medicine, Sapporo Medical University, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Hisahara","sequence":"additional","affiliation":[{"name":"Department of Neurology, School of Medicine, Sapporo Medical University, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Calabrese LH, Mallek JA. Primary angiitis of the central nervous system. report of 8 new cases, review of the literature, and proposal for diagnostic criteria. Medicine (Baltimore) 67: 20-39, 1988.","DOI":"10.1097\/00005792-198801000-00002"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Salvarani C, Hunder GG, Brown RD Jr. Primary central nervous system vasculitis. N Engl J Med 391: 1028-1037, 2024.","DOI":"10.1056\/NEJMra2314942"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Rice CM, Scolding NJ. The diagnosis of primary central nervous system vasculitis. Pract Neurol 20: 109-114, 2020.","DOI":"10.1136\/practneurol-2018-002002"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Song Y, Zhang W, Zhang L, et al. Cerebrospinal fluid IL-10 and IL-10\/IL-6 as accurate diagnostic biomarkers for primary central nervous system large B-cell lymphoma. Sci Rep 6: 38671, 2016.","DOI":"10.1038\/srep38671"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Wen J, Nie X, Zhou Q, et al. Elevated serum IL-10\/IL-6 ratio as a novel biomarker for secondary central nervous system lymphoma and poor prognosis in DLBCL. Front Immunol 16: 1656044, 2025.","DOI":"10.3389\/fimmu.2025.1656044"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Berthet E, Guillonnet A, Houillier C, et al. Unveiling the clinical and imaging signatures of intravascular lymphoma of the central nervous system: a multicentric cohort study. Ann Neurol 97: 435-448, 2025.","DOI":"10.1002\/ana.27132"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke 24: 35-41, 1993.","DOI":"10.1161\/01.STR.24.1.35"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Giannini C, Salvarani C, Hunder G, Brown RD. Primary central nervous system vasculitis: pathology and mechanisms. Acta Neuropathol 123: 759-772, 2012.","DOI":"10.1007\/s00401-012-0973-9"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Salvarani C, Brown RD Jr, Christianson TJH, et al. Adult primary central nervous system vasculitis treatment and course: analysis of one hundred sixty-three patients. Arthritis Rheumatol 67: 1637-1645, 2015.","DOI":"10.1002\/art.39068"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. de Boysson H, Zuber M, Naggara O, et al. Primary angiitis of the central nervous system: description of the first fifty-two adults enrolled in the French cohort of patients with primary vasculitis of the central nervous system. Arthritis Rheumatol 66: 1315-1326, 2014.","DOI":"10.1002\/art.38340"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Salvarani C, Brown RD Jr, Calamia KT, et al. Rapidly progressive primary central nervous system vasculitis. Rheumatology (Oxford) 50: 349-358, 2011.","DOI":"10.1093\/rheumatology\/keq303"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7758-26\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:30:23Z","timestamp":1790998223000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7758-26\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":11,"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.7758-26","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"7758-26"}}